Mengyao Tang

Nephrology
55 Fruit St
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

The Missing Axis: Cardiovascular-Kidney-Metabolic Risk After Gestational Diabetes.

The Missing Axis: Cardiovascular-Kidney-Metabolic Risk After Gestational Diabetes.

Journal: Kidney360
Published: July 30, 2026

Translating Carbamylation Biology into Precision Medicine for Kidney Disease.

Translating Carbamylation Biology into Precision Medicine for Kidney Disease.

Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: March 17, 2026

Boosting CONFIDENCE in Combination Therapy for Diabetic Kidney Disease in Asia.

Boosting CONFIDENCE in Combination Therapy for Diabetic Kidney Disease in Asia.

Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: December 05, 2025

Effect of Carbamylation and Anemia on the Association between Glycated Albumin and Kidney Outcomes in Diabetic Kidney Disease.

Effect of Carbamylation and Anemia on the Association between Glycated Albumin and Kidney Outcomes in Diabetic Kidney Disease.

Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: February 07, 2025

Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease.

Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease.

Journal: Journal of the American Society of Nephrology : JASN
Published: January 08, 2025

Clinical implications of mineralocorticoid receptor overactivation.

Clinical implications of mineralocorticoid receptor overactivation.

Journal: Clinical kidney journal
Published: July 29, 2024

In Reply to "Considerations on Potential Modifiers of Glycated Albumin Levels in Patients With CKD".

In Reply to "Considerations on Potential Modifiers of Glycated Albumin Levels in Patients With CKD".

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: May 14, 2024

Comparative CKD risk prediction using homocitrulline and carbamylated albumin: two circulating markers of protein carbamylation.

Comparative CKD risk prediction using homocitrulline and carbamylated albumin: two circulating markers of protein carbamylation.

Journal: BMC nephrology
Published: January 10, 2024

Glycated Albumin and Adverse Clinical Outcomes in Patients With CKD: A Prospective Cohort Study.

Glycated Albumin and Adverse Clinical Outcomes in Patients With CKD: A Prospective Cohort Study.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: December 18, 2023

Response to Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA1c's Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130-137.

Response to Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA1c's Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130-137.

Journal: Diabetes care
Published: May 15, 2023

Long-term Glycemic Variability: A Variable Glycemic Metric Entangled With Glycated Hemoglobin.

Long-term Glycemic Variability: A Variable Glycemic Metric Entangled With Glycated Hemoglobin.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: April 30, 2023

Protein Carbamylation and the Risk of ESKD in Patients with CKD.

Protein Carbamylation and the Risk of ESKD in Patients with CKD.

Journal: Journal of the American Society of Nephrology : JASN
Published: September 13, 2022
Showing 1-12 of 20

Last Updated: 09/26/2026